← FDA Drug Approvals (Drugs@FDA)
LEVOCARNITINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2026-09-30
Drug application
- FDA Application #
ANDA220181- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LEVOCARNITINE
- Generic name
- Levocarnitine
- Active ingredients
- LEVOCARNITINE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- GLAND
- First approval
- 2026-09-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown